Bacopa monniera (Institut Armand-Frappier)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBacopa monniera (Institut Armand-Frappier)
Drug Alias NameN/A
ClassificationSmall moleculesNatural product/Extract
Mechanisms of ActionMitochondrial complex I (NADH dehydrogenase) activators
TargetsMitochondrial complex I (NADH dehydrogenase)
Therapy Area/IndicationsParkinson Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesInrs-Institut Armand Frappier , Université Du Québec
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInrs-Institut Armand Frappier , Université Du Québec
Active IndicationsN/A
Inactive IndicationsParkinson Disease

Other Information

ATC CodeN/A
Related LinksN/A